Virtus ETF Advisers’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,336
Closed -$63.9K 489
2024
Q4
$63.9K Buy
7,336
+3,061
+72% +$26.7K 0.03% 428
2024
Q3
$83.5K Buy
4,275
+78
+2% +$1.52K 0.04% 409
2024
Q2
$86.4K Sell
4,197
-3,057
-42% -$62.9K 0.04% 378
2024
Q1
$155K Sell
7,254
-493
-6% -$10.5K 0.08% 326
2023
Q4
$111K Sell
7,747
-877
-10% -$12.6K 0.07% 327
2023
Q3
$78.7K Sell
8,624
-856
-9% -$7.81K 0.05% 363
2023
Q2
$100K Buy
9,480
+1,795
+23% +$19K 0.06% 378
2023
Q1
$94K Sell
7,685
-2,950
-28% -$36.1K 0.05% 349
2022
Q4
$132K Buy
10,635
+2,985
+39% +$37K 0.07% 386
2022
Q3
$104K Buy
7,650
+58
+0.8% +$788 0.04% 417
2022
Q2
$139K Sell
7,592
-5,009
-40% -$91.7K 0.05% 330
2022
Q1
$203K Sell
12,601
-753
-6% -$12.1K 0.09% 197
2021
Q4
$187K Buy
13,354
+4,263
+47% +$59.7K 0.07% 235
2021
Q3
$170K Sell
9,091
-481
-5% -$9K 0.07% 310
2021
Q2
$200K Buy
9,572
+2,304
+32% +$48.1K 0.08% 347
2021
Q1
$205K Buy
7,268
+132
+2% +$3.72K 0.09% 326
2020
Q4
$233K Sell
7,136
-11,771
-62% -$384K 0.1% 328
2020
Q3
$579K Sell
18,907
-2,572
-12% -$78.8K 0.3% 116
2020
Q2
$350K Sell
21,479
-2,850
-12% -$46.4K 0.17% 265
2020
Q1
$242K Sell
24,329
-3,543
-13% -$35.2K 0.1% 258
2019
Q4
$383K Buy
27,872
+14,306
+105% +$197K 0.06% 274
2019
Q3
$206K Sell
13,566
-756
-5% -$11.5K 0.04% 244
2019
Q2
$282K Sell
14,322
-5,119
-26% -$101K 0.06% 243
2019
Q1
$323K Sell
19,441
-2,529
-12% -$42K 0.69% 54
2018
Q4
$308K Sell
21,970
-3,468
-14% -$48.6K 0.05% 104
2018
Q3
$445K Sell
25,438
-18,195
-42% -$318K 0.05% 141
2018
Q2
$794K Sell
43,633
-11,650
-21% -$212K 0.7% 33
2018
Q1
$1.04M Buy
55,283
+29,635
+116% +$556K 0.9% 36
2017
Q4
$392K Buy
+25,648
New +$392K 0.49% 57